Home » Newsletters » BioWorld Science

BioWorld Science

March 3, 2010

View Archived Issues

Dual IL-4/IL-13 receptor antagonist AER-003 reduces AHR in primates

Phase III data support use of mannitol test to identify EIB and asthma in children

Maraviroc analogue UK-484900 inhibits AHR in mice

Concert Pharmaceuticals discloses deuterated dual SV2A/Na channel blockers

Phase III data support icatibant safety and efficacy in acute HAE

Clinical data support combination of oxymetazoline and mometasone furoate for nasal congestion

Rigel identifies AXL kinase inhibitors for cancer therapy

BioDelivery Sciences presents update on BEMA Buprenorphine

Memory and Roche discover new PDE4 inhibitors

Neuraxon identifies nNOS inhibitors as analgesics

Bayer Schering claims new polo-like kinase 1 inhibitors

Antares completes enrollment in phase III Anturol trial in overactive bladder

EMA accepts voclosporin for regulatory review

Inovio to begin clinical trial of H5N1 flu DNA vaccine in Korea

InterMune submits MAA for pirfenidone for treatment of idiopathic pulmonary fibrosis

Synta resumes clinical development of elesclomol

Astellas commences tender offer to acquire OSI Pharmaceuticals

Shionogi and QuatRx to market and develop ospemifene

FDA reschedules meeting on ChemGenex's application for Omapro in CML

Renovo and Shire revise licensing deal for Juvista

FDA recommends approval of Bristol-Myers Squibb's belatacept

Celsion to begin phase II trial of ThermoDox and RFA for colorectal liver metastases

Orphan drug designation for Lithera's LIPO-102

Lundbeck inlicenses marketing rights to Azilect in Asian countries

Abbott and Enanta advance their hepatitis C collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.